Discovery Life Sciences Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con in San DiegoUSA - EnglishUSA - EnglishUSA - españolUSA - FrançaisUSA - Deutsch

Global Biospecimen Leader to Unveil Transformative Tool for Oncology Studies

HUNTSVILLE, Ala., Feb. 25, 2025 — Discovery Life Sciences (Discovery), a global leader in biospecimen solutions and specialty lab services, announced today that it will launch a new product to help advance oncology research, Tumoroid Cell Lines, OncoPro™ Medium-Derived, at Precision Med Tri-Con 2025, March 11-13 in San Diego, California.

To learn about Discovery's new tumoroid cell lines, which are derived and expanded in Thermo Fisher Scientific's Gibco™ OncoPro™ Tumoroid Culture Medium, click here.

Tumoroid